Act I · Physical & Clinical Story
Why Antibiotics Stall Inside a 200-Micrometer Mucus Plug
Bacterial colonies trapped inside living tissues do not behave like the free floating cells cultured on liquid laboratory dishes. When Philip Stewart published his landmark review on diffusion through bacterial biofilms in the Journal of Bacteriology during two thousand three, he unmasked a quiet biophysical mechanism that explains why potent antibiotic drugs frequently fail inside human airways. A bacterial biofilm functions like an active chemical reactor where tightly clustered cells and defending host white blood cells rapidly consume dissolved oxygen before it can reach the bottom layers. Because diffusion through thick airway mucus is slow, oxygen levels plummet to absolute zero deep within the bacterial plug. Starved of oxygen, the underlying bacteria stop dividing and shut down their electrical membrane engines, preventing traditional medicines from entering their cell bodies. This dormant physical state shields the bacterial colony from destruction without requiring any new genetic resistance mutations.
To understand this puzzle, picture a crowded room packed with thousands of lively dancers. The individuals standing near open windows breathe fresh outdoor air and continue dancing with vigor. Those crowded deep into the stagnant center rapidly exhaust the oxygen supply and collapse into an exhausted motionless heap. Bacterial colonies nested inside deep airway mucus behave in this exact same manner. Because oxygen cannot diffuse past the active outer boundary, bacteria buried in the core shut down their internal metabolism and enter a durable dormant sleep. Inhaled antibiotic molecules require an active electrical charge across the bacterial membrane to enter the cytoplasm, so these dormant cells remain completely unharmed. Specialized bacterial viruses known as bacteriophages carry specialized digestive enzymes that carve physical channels directly through the dense mucus shield. By reopening oxygen conduits and thinning the protective shell, these viral therapies wake the sleeping microbes, restoring their natural vulnerability to conventional antibiotics.
Everyday Analogy: Consider a massive mound of damp grass clippings piled high in a backyard corner. Fresh breezes easily circulate through the loose strands near the surface, keeping the outer clippings cool and dry. Deeper down beneath several heavy feet of decomposing material, air cannot penetrate the tightly compacted organic mass. Because living microbes in the upper layers rapidly consume every molecule of oxygen, the center of the pile turns completely stagnant and dark. Gardeners plunge a metal aerating pitchfork into the heap to pierce ventilation shafts and restore circulating air currents. In a similar fashion, lytic bacteriophages act like microscopic aeration prongs, cutting physical tunnels through bacterial slime so oxygen and medicinal compounds can reach suffocated depths. This analogy breaks down because garden compost contains inert plant cellulose, whereas living biofilms continually alter their surrounding polymer mesh and evolve receptor mutations in response to physical intrusion.
How the Two Sliders Work in Plain Words: Before exploring the mathematical equations of reaction-diffusion kinetics, picture the two primary controls in our interactive simulation as physical dials governing an infected airway. The first control sets the Biofilm or Mucus Plug Thickness, adjusting how many micrometers of dense polymeric material separate the airway lumen from the underlying tissue. Expanding this thickness rapidly elevates the reaction-diffusion Thiele modulus, which measures whether oxygen consumption outpaces inward gas diffusion. When this barrier becomes too deep, the Basal Biofilm Oxygen Fraction drops toward zero, suffocating the core. The second control governs the Inhaled Phage plus Depolymerase Dose Factor, which determines how aggressively viral enzymes carve through the protective hydrogel. As viral particles penetrate the matrix, our readouts track the MexAB-OprM Efflux Trade-Off State and the resulting Log10 CFU per gram Sputum Reduction. Together, these controls reveal how physical clearing of the mucus architecture directly restores antibiotic susceptibility.
Activated neutrophils swarming around the mucus plug consume dissolved oxygen to fuel their respiratory burst, while bacteria in the outer 50 micrometers of the biofilm respire the rest. Because molecular oxygen diffuses through dense mucin/alginate hydrogel at only D_O2 ≈ 1.5 × 10⁻⁵ cm²/s, the core of the plug drops to zero oxygen. Deprived of aerobic electron transport, deep-layer bacteria lower their membrane electrical potential ΔΨ—shutting the very door that cationic aminoglycosides need to enter the bacterial cytoplasm.
Chronic Pseudomonas aeruginosa airway infections represent one of the most resilient physical transport barriers encountered in respiratory medicine. As detailed in Philip Stewart's primary analysis in the Journal of Bacteriology (PMID 12591863), thick mucus matrices impede neither small solute diffusion nor molecular mobility directly. Instead, the severe loss of antibiotic efficacy emerges from localized reaction-diffusion imbalances within the dense biopolymer framework. When active inflammatory infiltrates and rapidly respiring bacterial aggregates consume dissolved oxygen at rates exceeding convective replenishment, steep chemical gradients form across microscopic distances. Within less than one hundred micrometers of spatial penetration, the local oxygen tension collapses completely to anoxic levels. Deprived of terminal electron acceptors, deep bacterial subpopulations enter anaerobic quiescence and downregulate membrane-potential-dependent aminoglycoside uptake pathways. Translational failure in chronic airway management often reflects this biophysical shielding rather than classical genetic resistance mutations. Developing therapeutic strategies that enzymatically digest the exopolysaccharide mesh and collapse these hypoxic microenvironments is therefore critical for restoring chemical accessibility to dormant bacterial reservoirs.
“Completes Pillar III by linking mucus reaction-diffusion physics (Thiele modulus Φ) with evolutionary phage steering (MexAB-OprM efflux vs phage resistance trade-offs) to protect the airway while therapeutic therapies work.”
— Cross-Pillar Research Thread · Grounded in Stewart (2003), Journal of Bacteriology 185(5):1485-1491 — Diffusion in Biofilms (PMID 12591863).
Key Parameters, Readouts & Primary Anchor
| Quantity / Anchor | Pinned Baseline | Physical / Clinical Role |
|---|---|---|
| Biofilm / Mucus Plug Thickness (L_plug) | 160.0 μm |
Primary perturbation axis (40.0 to 300.0 μm) |
| Inhaled Phage + Depolymerase Dose Factor | 1.2× MOI boost |
Coupled co-perturbation axis (0.0 to 2.0× MOI boost) |
| Reaction-Diffusion Thiele Modulus Φ & Basal Biofilm Oxygen Fraction [O₂](L)/[O₂]₀ | 1.42 (Oxygen-Repleted Core) · 45.6% (PMF Active for Tobramycin) |
Baseline biophysical operating point |
| Primary Literature Anchor | DOI 10.1128/JB.185.5.1485-1491.2003 | Stewart (2003), Journal of Bacteriology 185(5):1485-1491 — Diffusion in Biofilms (PMID 12591863). · Kernel src/scripts/delivery-biofilm-phage.js |
Act II · From Intuition to Governing Law
The Thiele Modulus Φ = L√(k_resp / D_O2) and Evolutionary
In chemical reaction engineering, the competition between reaction rate and diffusion across a slab of thickness L is governed by the dimensionless Thiele modulus Φ = L √(k_resp / D_O2). Solving the steady-state reaction-diffusion equation D_O2 d²C/dz² = k_resp C with surface concentration C(0) = C_0 and zero flux at the plug base (dC/dz|_{z=L} = 0) yields the concentration profile C(z) / C_0 = cosh(Φ (1 − z/L)) / cosh(Φ). At the base of the biofilm (z = L), oxygen availability is simply 1 / cosh(Φ): when L doubles so Φ rises from 1.0 to 3.0, basal oxygen plunges from 64.8% to 9.9%! Lytic bacteriophages attack this barrier on two fronts: their virion-associated depolymerases thin L (lowering Φ and re-awakening aerobic antibiotic uptake), while evolutionary selection by OprM-binding phages (such as phage OMKO1, Stewart, J. Bacteriol. 2003, PMID 12591863; Chan et al., Sci. Rep. 2016) forces bacteria into an evolutionary corner where escaping the phage disables their multidrug antibiotic efflux pump.
The mathematical physics of solute penetration within cellular aggregates rests on steady-state mass conservation governed by Fickian diffusion coupled to volumetric metabolic consumption. In the formulation developed by Stewart in the Journal of Bacteriology (PMID 12591863), the spatial distribution of dissolved oxygen across a one-dimensional biofilm slab of thickness L is modeled by the differential balance D_O2 (d²[O2]/dz²) = k_resp [O2], where D_O2 represents the effective molecular diffusivity of oxygen in the alginate-mucin matrix and k_resp is the first-order volumetric respiratory consumption rate constant. Defining the dimensionless coordinate zeta = z / L and normalizing concentration by luminal boundary oxygen [O2]_0 yields the characteristic dimensionless group known as the Thiele modulus, Φ = L sqrt(k_resp / D_O2). Imposing Dirichlet boundary conditions at the exposed luminal surface [O2](0) = [O2]_0 alongside a zero-flux Neumann boundary condition at the epithelial interface (d[O2]/dz at z = L = 0) yields the closed-form hyperbolic solution [O2](z) / [O2]_0 = cosh(Φ (1 - z / L)) / cosh(Φ). This analytical expression demonstrates that when the Thiele modulus exceeds unity, internal oxygen tension decays exponentially.
At the basal boundary z = L, the residual oxygen fraction reduces cleanly to the reciprocal hyperbolic cosine 1 / cosh(Φ), revealing that modest increases in mucus plug thickness trigger catastrophic anoxia in the bacterial core. Because aminoglycoside antibiotics like tobramycin require an electron-transport-generated proton-motive force across the bacterial inner membrane for active transport, this oxygen deficit induces phenotypic drug tolerance. In our computational simulation engine encoded in src/scripts/delivery-biofilm-phage.js, this reaction-diffusion boundary is coupled directly to phage-mediated matrix thinning. As lytic virions release polysaccharide depolymerases, the physical thickness L contracts dynamically over time, driving Φ downward and systematically restoring the basal oxygen fraction toward aerobic thresholds where antibiotic susceptibility is reactivated.
Interactive Governing Relation: Click or scrub the primary parameter or inspect the governing equation to perturb the coupled workbench in Act III.
Four-Stage Mechanistic Progression
- Stage 1 (Alginate & Pel/Psl Matrix Entrapment): Mucoid P. aeruginosa (mucA variants) secretes negatively charged alginate chains that crosslink with Ca²⁺ and electrostatic eDNA, sequestering cationic aminoglycosides (tobramycin/amikacin) in the outer shell.
- Stage 2 (Thiele Reaction-Diffusion Hypoxia — Φ = L√(k/D) > 2): Intense O₂ consumption by surrounding PMN respiratory bursts (NADPH oxidase) and superficial bacteria depletes dissolved O₂ within ~80–120 μm, forcing deep bacteria into denitrification/dormancy where PMF-dependent aminoglycoside uptake halts.
- Stage 3 (Phage Alginate Lyase & Biofilm Channeling): Lytic bacteriophages carrying polysaccharide depolymerases cleave the alginate/Pel matrix and lyse outer-shell cells, shrinking effective plug thickness L and restoring O₂ penetration (cosh(Φ)⁻¹ rises).
- Stage 4 (Evolutionary Receptor Steering — OprM & Type IV Pili): When phages use the outer-membrane efflux protein OprM (of the MexAB-OprM multidrug efflux pump) or Type IV pili as their entry receptor, phage-resistant bacterial mutants downregulate OprM or lose twitching motility—re-sensitizing the population to β-lactams and fluoroquinolones.
Act III · Interactive Visual Experiment & Plain-Language Lens
Try It Yourself: Biofilm Thiele Modulus & Phage–Antibiotic Synergy
Vary biofilm plug thickness (L_plug) and inhaled phage + depolymerase dose to compute the Thiele modulus Φ, basal oxygen fraction 1/cosh(Φ), and combined bacterial clearance.
Chronic airway bacteria such as Pseudomonas aeruginosa weave a negatively charged slime matrix (alginate and DNA) that binds positively charged inhaled antibiotics like tobramycin in the top layer before the drug can diffuse to the bottom. Bacteriophages carry natural enzymes (depolymerases) that snip that slime matrix open—carving channels so both phages and conventional antibiotics can reach dormant bacteria at the base. Drag the plug thickness and phage dose sliders to watch the concentration curve reach the floor.
Questions to discuss with a CF care team: What is the current status of inhaled bacteriophage trials for chronic Pseudomonas infections alongside standard inhaled antibiotics?
What this diagram leaves out: Models 1D reaction-diffusion across a flat slab without host neutrophil dynamics or phage-resistance evolution.
Biofilm Penetration Activity · Mode: Biophysical Sandbox · How to explore this model
- Test the four physical regimes: Click the four scenario presets below (1 · Alginate & Pel/Psl Matrix… through 4 · Evolutionary Receptor…) to jump directly between experimental conditions.
- Perturb the primary control: Drag Biofilm / Mucus Plug Thickness (L_plug) (40.0 to 300.0 μm) and observe how the visual schematic and readouts respond.
- Explore coupled co-perturbation: Adjust Inhaled Phage + Depolymerase Dose Factor (0.0 to 2.0× MOI boost) to test synergy against
D_O2 d²[O2]/dz² = k_resp [O2] · Φ = L √(k_resp / D_O2) · [O2](z)/[O2]_0 = cosh(Φ(1 − z/L)) / cosh(Φ).
Governing law: D_O2 d²[O2]/dz² = k_resp [O2] · Φ = L √(k_resp / D_O2) · [O2](z)/[O2]_0 = cosh(Φ(1 − z/L)) / cosh(Φ)
D_O2 d²[O2]/dz² = k_resp [O2] · Φ = L √(k_resp / D_O2) · [O2](z)/[O2]_0 = cosh(Φ(1 − z/L)) / cosh(Φ)
Normalized Sensitivity (Stages 1–4)
Want to test this mechanism inside the full multi-module pillar observatory? Open the coupled interactive workbench on the Pillar Hub.
Act IV · Clinical & Therapeutic Horizon
Preserving Lung Architecture Across Every Age
Protecting conducting airways from irreversible bronchiectasis ensures that when a person with a rare or Class I genotype receives an RNA or gene-editing therapy, the bronchial tree remains structurally intact to receive it. Now let us step into Pillar IV (math/), where we examine how formal mathematical proof verifiers (Lean 4), non-equilibrium stochastic thermodynamics, and global registry denominator equations verify that every claim across Pillars I–III rests on primary truth. Grounded in Lab Discovery Catalog modules: `phage_biofilm_kinetics`, `phage_depolymerase_biofilm_synergy`, `phage_omko1_tradeoff`, `phage_biofilm_penetration_coevolution`, `alginate_lyase_phage_synergy`.
The translational boundary between laboratory antimicrobial assays and in vivo respiratory delivery exposes the profound limitations of conventional minimum inhibitory concentration metrics. Standard suspension cultures fail to reflect the severe diffusion-reaction gradients present in people with cystic fibrosis, particularly those harboring rare Class I nonsense variants or established structural bronchiectasis where thick mucus plugs persist despite modulator therapy. Because these dense physical barriers prevent aminoglycosides from achieving bactericidal intracellular concentrations, aerosolized therapy must be evaluated using spatially resolved continuum models rather than macroscopic dilution plates. Coupling bacteriophage depolymerases with inhaled antibiotics provides an evolutionary lever, as phage exploitation of the outer-membrane efflux channel OprM forces bacterial survivors to downregulate their multidrug pumps to gain viral resistance, thereby resensitizing them to beta-lactam therapies.
Computational verification of these coupled kinetic phenomena establishes formal mathematical envelopes for delivery timing without making clinical efficacy claims. Within our verified modeling pipeline, numerical simulations integrate the Stewart reaction-diffusion kernel with non-linear phage replication dynamics to quantify the transient window wherein plug thinning re-establishes aerobic respiration. Sensitivity analysis across varying plug geometries reveals that therapeutic synergy depends strictly on maintaining viral persistence above the clearance threshold of the mucociliary escalator. By validating these biophysical rate constants against published experimental transport benchmarks across both pediatric and adult airway anatomies, this computational framework provides a rigorous, reproducible foundation for evaluating adjuvant antimicrobial delivery strategies across diverse patient airway microenvironments.
Primary Anchor: Stewart (2003), Journal of Bacteriology 185(5):1485-1491 — Diffusion in Biofilms (PMID 12591863). (DOI 10.1128/JB.185.5.1485-1491.2003 · PubMed 12591863).
Governed by biophysical kernel src/scripts/delivery-biofilm-phage.js and cross-checked in the Open Biofilm Reaction-Diffusion & Phage Synergy Workbench on /cf/delivery/.
Resumen Científico en Español (ES-MX) · Folio D.06
Biopelículas Polimicrobianas, Gradientes de Reacción-Difusión Hipóxicos y Sinergia Fago–Antibiótico: Cómo las biopelículas y los neutrófilos crean zonas hipóxicas (módulo de Thiele Φ > 1) y cómo los bacteriófagos líticos restauran la sensibilidad a los antibióticos.
Incluso bajo terapia moduladora, muchos adultos con bronquiectasias establecidas mantienen biopelículas crónicas de Pseudomonas aeruginosa. El consumo de oxígeno por neutrófilos y bacterias crea zonas hipóxicas profundas donde disminuye la eficacia de los aminoglucósidos, hasta que los bacteriófagos líticos rompen la matriz y revierten las bombas de eflujo.
En Palabras Sencillas: Para entender este dilema, imaginemos una habitación llena con miles de bailarines. Quienes están cerca de las ventanas respiran aire fresco y continúan moviéndose con vigor. Quienes quedan atrapados en el centro estancado agotan el oxígeno y caen exhaustos en reposo. Las colonias de bacterias en los tapones profundos de moco actúan exactamente igual. Como el oxígeno no puede cruzar la capa exterior activa, las bacterias del núcleo apagan su metabolismo y caen en un letargo protector. Los antibióticos inhalados necesitan una carga eléctrica activa en la membrana para ingresar, por lo que estas células dormidas resultan ilesas. Los bacteriófagos poseen enzimas que perforan túneles físicos por el escudo de moco. Al restaurar la ventilación y reducir el espesor del gel, estos virus despiertan a los microbios y devuelven su vulnerabilidad habitual frente a los antibióticos.
Analogía Cotidiana: Pensemos en una gran pila de pasto cortado en el rincón de un jardín. La brisa circula fácilmente por las capas superiores, manteniéndolas frescas y aireadas. Sin embargo, debajo de varios centímetros de material compactado, el aire no puede entrar. Los microorganismos de la superficie consumen todo el oxígeno disponible y el centro queda completamente anóxico y oscuro. Para reactivar el proceso, los jardineros clavan una horquilla metálica y abren conductos de ventilación. De forma similar, los bacteriófagos líticos funcionan como pequeñas herramientas que perforan el moco para que el oxígeno y los fármacos lleguen a las zonas sofocadas. Esta analogía deja de ser exacta porque el pasto de jardín es materia vegetal inerte, mientras que las biopelículas vivas ajustan continuamente su matriz polimérica y desarrollan mutaciones defensivas ante la invasión.
Guía de Controles Interactivos: Antes de analizar las fórmulas de reacción y difusión, conviene visualizar los dos controles principales como perillas físicas en una vía respiratoria infectada. El primer control ajusta el espesor del tapón de moco o biopelícula, determinando la distancia que separa el aire del tejido subyacente. Al aumentar este espesor, el módulo de Thiele se eleva rápidamente, indicando que el consumo celular de oxígeno supera la difusión del gas. Cuando la barrera es muy gruesa, la fracción de oxígeno en la base cae a cero y el núcleo se asfixia. El segundo control regula la dosis de bacteriófagos inhalados con despolimerasas, que desgastan enzimáticamente el hidrogel protector. Los paneles de resultados muestran el estado de las bombas de eflujo MexAB-OprM y la reducción bacteriana lograda. Ambos controles demuestran cómo la alteración física del moco restablece la eficacia de los antibióticos.
Riesgo Biofísico y Clínico: Las infecciones respiratorias crónicas por Pseudomonas aeruginosa constituyen una de las barreras de transporte físico más resistentes en medicina pulmonar. Según el análisis de Philip Stewart en Journal of Bacteriology (PMID 12591863), las matrices densas de moco no impiden de forma directa la difusión de solutos pequeños. La pérdida de eficacia antibiótica surge de desequilibrios locales entre la reacción y la difusión en la red polimérica. Cuando los neutrófilos activos y las bacterias superficiales consumen oxígeno más rápido de lo que este se repone, se generan gradientes químicos abruptos en distancias microscópicas. En menos de cien micrómetros de profundidad, la tensión de oxígeno colapsa a niveles anóxicos. Sin aceptores de electrones, las bacterias profundas entran en reposo y desactivan el transporte de aminoglucósidos dependiente del potencial de membrana. El fracaso terapéutico refleja este blindaje físico más que mutaciones genéticas clásicas. Diseñar estrategias que degraden enzimáticamente la matriz es fundamental para reactivar el acceso químico a las bacterias latentes.
Derivación Formal: La física del transporte de solutos en agregados celulares se fundamenta en la conservación de masa en estado estacionario mediante difusión fickeana acoplada a consumo metabólico volumétrico. En el modelo desarrollado por Stewart en Journal of Bacteriology (PMID 12591863), la distribución espacial de oxígeno disuelto en una capa de biopelícula de espesor L se rige por D_O2 (d²[O2]/dz²) = k_resp [O2], donde D_O2 es la difusividad efectiva y k_resp es la constante de consumo respiratorio. Al normalizar con la coordenada adimensional zeta = z / L y la concentración luminal [O2]_0, surge el módulo adimensional de Thiele, Φ = L sqrt(k_resp / D_O2). Con condiciones de frontera de Dirichlet en la superficie y de flujo nulo en la base, la solución analítica es [O2](z) / [O2]_0 = cosh(Φ (1 - z / L)) / cosh(Φ), demostrando que si Φ supera la unidad, el oxígeno decae exponencialmente. En la base z = L, la fracción residual de oxígeno se reduce a 1 / cosh(Φ), mostrando que incrementos moderados en el espesor del moco inducen anoxia profunda. Dado que los aminoglucósidos como la tobramicina requieren una fuerza protón-motriz generada por respiración aeróbica para ingresar a la bacteria, este déficit de oxígeno genera tolerancia fenotípica. En nuestro núcleo de cálculo en src/scripts/delivery-biofilm-phage.js, esta frontera de reacción-difusión se vincula con la degradación enzimática de la matriz por bacteriófagos. Conforme las partículas líticas liberan despolimerasas, el espesor L disminuye dinámicamente, reduciendo el valor de Φ y restituyendo la oxigenación basal indispensable para reactivar la sensibilidad antibiótica.
Frontera Traslacional: La brecha traslacional entre los ensayos in vitro y la administración pulmonar in vivo evidencia las limitaciones de la concentración inhibitoria mínima estándar. Los cultivos bacterianos en suspensión no reproducen los pronunciados gradientes de reacción y difusión presentes en pacientes con fibrosis quística, especialmente quienes tienen mutaciones raras de Clase I o bronquiectasias avanzadas donde persisten tapones densos de moco. Como estas barreras impiden alcanzar concentraciones bactericidas, las terapias en aerosol deben evaluarse mediante modelos continuos con resolución espacial. El uso combinado de despolimerasas de bacteriófagos y antibióticos genera además una presión evolutiva favorable: al explotar la proteína OprM de las bombas de eflujo, los fagos seleccionan mutantes que pierden dichas bombas, restaurando la susceptibilidad a los betalactámicos. La verificación computacional de estos fenómenos cinéticos acoplados define límites matemáticos para los intervalos de dosificación sin formular promesas clínicas no verificadas. En nuestro entorno de modelado, las simulaciones integran la ecuación de Stewart con la replicación viral para calcular el período en el cual el adelgazamiento del moco recupera la respiración aeróbica. Los análisis de sensibilidad demuestran que la sinergia terapéutica depende de mantener la persistencia viral frente al aclaramiento mucociliar. Al calibrar estas constantes frente a datos de transporte experimentales, este esquema ofrece una base determinista para evaluar estrategias antimicrobianas en la heterogeneidad de las vías respiratorias.
Horizonte terapéutico: Completa el Pilar III vinculando la física de reacción-difusión (módulo de Thiele Φ) con la dirección evolutiva mediante bacteriófagos (compensación entre bombas de eflujo MexAB-OprM y receptores fágicos). Investigación independiente, no asesoramiento médico.
Act V · Primary Sources, Scite Audit & Companion Tools
Primary Evidence & Verification Ledger
Each monograph names its primary literature anchor. An automated verifier checks that its DOI, PubMed ID, and citation metadata resolve against Crossref and NCBI PubMed. Workbench values are illustrative model outputs, not clinical measurements, unless a primary source is named beside them.
- Primary Literature Receipt: Stewart (2003), Journal of Bacteriology 185(5):1485-1491 — Diffusion in Biofilms (PMID 12591863). (DOI 10.1128/JB.185.5.1485-1491.2003 · PubMed 12591863).
- Citation Context (Scite): Inspect how later literature cites 10.1128/JB.185.5.1485-1491.2003 on Scite.ai ·
Crossref + Scite verified (data/folio-citations.cache.json · fetched 2026-11-08 · 1,249 citing · 29 supporting · 966 mentioning · 3 contrasting). - Open-Source Computational & Epistemic Engine: FEniCSx / DOLFINx Variational Reaction-Diffusion Biofilm PDE Solver (DOI 10.1145/3524456 · Scite Report).
- Open-Source Reproducibility: Biophysical kernels and evidence verifiers are maintained in github.com/senseiewok/cf-research and github.com/senseiewok/cf-skills.
For builders: method, companion SKILL.md, Python verifier, and edition history (REV 1.1)
cf-biofilm-thiele-phage-synergy-SKILL.md · Kernel src/scripts/delivery-biofilm-phage.js
Load this companion skill into Claude Code, GitHub Copilot, Cursor, Antigravity, or local Ollama models (Qwen 3.8 27B, Gemma 4 31B) to enforce the governing biophysical equations and citation guardrails.
View raw SKILL.md source
--- name: cf-biofilm-thiele-phage-synergy description: AI-agnostic biophysics and microbiology skill for CF airway biofilm reaction-diffusion (Thiele modulus Phi = L*sqrt(k/D)), hypoxic aminoglycoside tolerance, and evolutionary phage-antibiotic synergy. license: CC-BY-4.0 --- # D.06 — Biofilm Reaction-Diffusion (Thiele Φ) & Phage–Antibiotic Synergy ## Governing Biophysical / Mathematical Law D_O2 d²[O2]/dz² = k_resp [O2] · Φ = L √(k_resp / D_O2) · [O2](z)/[O2]_0 = cosh(Φ(1 − z/L)) / cosh(Φ) ## Primary Evidence Receipt - **Citation:** Stewart (2003), Journal of Bacteriology 185(5):1485-1491 — Diffusion in Biofilms (PMID 12591863). - **DOI:** https://doi.org/10.1128/JB.185.5.1485-1491.2003 - **PubMed PMID:** https://pubmed.ncbi.nlm.nih.gov/12591863/ - **Answer Tier:** T2 · Sourced Microbiology & Reaction-Diffusion Model ## Verification Rules - Compute basal biofilm oxygen penetration via C(L)/C_0 = 1 / cosh(Phi) where Phi = L * sqrt(k_resp / D_O2). - Couple aerobic proton-motive force (Delta Psi) to active aminoglycoside uptake in P. aeruginosa. - Ground biofilm reaction-diffusion physics in Stewart 2003 (DOI 10.1128/JB.185.5.1485-1491.2003, PMID 12591863). ## Safety & Clinical Boundary Research synthesis and biophysical modeling only — never medical advice, clinical guidance, or a treatment promise.
REV 1.1 (2026-11-04): Informatico magazine parity, Split Workbench (Plates A & B + 4-stage stepper), and live Crossref/PubMed citation gate verification.
Verified 5-Act magazine flow, untruncated headings, and bilingual EN / ES-MX structural parity.
Audited clinical dignity boundaries, non-promise guardrails, and discovery catalog coverage.
check_folio_citations.py
Verified DOI 10.1128/JB.185.5.1485-1491.2003 against Crossref and NCBI PubMed metadata.
src/scripts/delivery-biofilm-phage.js
Coupled governing relation D_O2 d²[O2]/dz² = k_resp [O2] · Φ = L √(k_re to interactive Plates A & B.